Status:
UNKNOWN
Expression of MCM5 in Urine in Patients With Urothelial Cancers
Lead Sponsor:
Medical University of Warsaw
Conditions:
Bladder Cancer
Eligibility:
All Genders
18+ years
Brief Summary
In patients with non-muscle-invasive bladder cancer, the development and introduction to the clinical practice of an adequately accurate biomarker may allow to limit the indications for performing con...
Eligibility Criteria
Inclusion
- age \>18 years,
- written consent to participate in the study,
- ability to void and collect \>50ml of urine,
- recurrent bladder cancer confirmed by cystoscopy (group 1) or upper urinary tract tumor confirmed by imaging studies (group 2) or no history of urological/gynecological cancers (controls)
Exclusion
- urinary tracy infection,
- nephrolithiasis
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2019
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT03796299
Start Date
January 1 2019
End Date
October 1 2019
Last Update
January 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Warsaw, Dept. of Urology
Warsaw, Poland, 02005